Price T Rowe Associates Inc Cardlytics, Inc. Transaction History

Price T Rowe Associates Inc

$812 Billion
Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Cardlytics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 63,485 shares of CDLX stock, worth $119,351. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,485

Previous 62,471 1.62%

Holding current value

$119,351

Previous $232,000 50.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$1.81 - $3.9 $1,835 - $3,954	1,014 Added 1.62%	63,485 $116,000
Q4 2024 Feb 14, 2025	BUY	$3.06 - $5.21 $70,982 - $120,856	23,197 Added 59.06%	62,471 $232,000
Q3 2024 Nov 14, 2024	BUY	$2.96 - $9.15 $22,792 - $70,455	7,700 Added 24.39%	39,274 $126,000
Q2 2024 Aug 14, 2024	BUY	$8.03 - $15.41 $14,494 - $27,815	1,805 Added 6.06%	31,574 $260,000
Q1 2024 May 15, 2024	BUY	$5.77 - $20.25 $10,235 - $35,923	1,774 Added 6.34%	29,769 $432,000
Q4 2023 Feb 14, 2024	BUY	$6.11 - $14.1 $31,087 - $71,740	5,088 Added 22.21%	27,995 $258,000
Q3 2023 Nov 14, 2023	SELL	$5.78 - $19.17 $40,893 - $135,627	-7,075 Reduced 23.6%	22,907 $378,000
Q2 2023 Aug 14, 2023	BUY	$3.45 - $8.29 $3,467 - $8,331	1,005 Added 3.47%	29,982 $190,000
Q1 2023 May 15, 2023	BUY	$2.6 - $8.98 $17,160 - $59,268	6,600 Added 29.49%	28,977 $99,000
Q4 2022 Feb 14, 2023	SELL	$3.67 - $10.06 $1,368 - $3,752	-373 Reduced 1.64%	22,377 $129,000
Q3 2022 Nov 14, 2022	BUY	$9.32 - $23.54 $48,184 - $121,701	5,170 Added 29.41%	22,750 $214,000
Q2 2022 Aug 15, 2022	BUY	$21.88 - $57.86 $25,905 - $68,506	1,184 Added 7.22%	17,580 $392,000
Q1 2022 May 16, 2022	BUY	$42.67 - $72.15 $46,595 - $78,787	1,092 Added 7.14%	16,396 $901,000
Q4 2021 Feb 14, 2022	SELL	$62.36 - $92.74 $28,935 - $43,031	-464 Reduced 2.94%	15,304 $1.01 Million
Q3 2021 Nov 15, 2021	BUY	$77.81 - $132.88 $73,530 - $125,571	945 Added 6.38%	15,768 $1.32 Million
Q2 2021 Aug 16, 2021	SELL	$88.36 - $141.98 $37,376 - $60,057	-423 Reduced 2.77%	14,823 $1.88 Million
Q1 2021 May 17, 2021	BUY	$109.42 - $157.18 $276,613 - $397,351	2,528 Added 19.88%	15,246 $1.67 Million
Q4 2020 Feb 16, 2021	BUY	$71.51 - $146.08 $909,464 - $1.86 Million	12,718 New	12,718 $1.82 Million

Others Institutions Holding CDLX

# of Institutions

124

Shares Held

28.9M

Call Options Held

282K

Put Options Held

493K

View Full List

About Cardlytics, Inc.

Ticker CDLX
Exchange NASDAQ
Sector Communication Services
Industry Advertising Agencies
Shares Outstandng 32,893,800
Market Cap $61.8M
Description
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...

More about CDLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Cardlytics, Inc. Transaction History